Wexford Capital’s MediciNova MNOV Stock Holding History

Wexford Capital’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-88,250	Closed	-$850K	–	141
2019 Q2	$850K	Sell	88,250 -36,750	-29%	-$387K	0.1%	90
2019 Q1	$1.03M	Hold	125,000	–	–	0.09%	68
2018 Q4	$1.02M	Hold	125,000	–	–	0.09%	50
2018 Q3	$1.56M	Hold	125,000	–	–	0.1%	89
2018 Q2	$995K	Hold	125,000	–	–	0.06%	87
2018 Q1	$1.28M	Buy	+125,000	New	+$1.25M	0.09%	68

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wexford Capital's MNOV Position: Q3 2019 in Review

Wexford Capital sold out of MediciNova (MNOV) in Q3 2019, closing a stake of 88,250 shares — an estimated $850K sold.

Wexford Capital first reported a position in MNOV in Q1 2018 and held it in 6 quarters. The position peaked at $1.56M in Q3 2018. 49 funds tracked by Wall St. Rank hold MNOV as of Q3 2019.

Wexford Capital reported no remaining MediciNova position as of Q3 2019 after selling out during the quarter.
Wexford Capital sold 88,250 MediciNova shares in Q3 2019, an estimated $850K.
Wexford Capital first reported a position in MediciNova in Q1 2018 and held it in 6 quarters.
Wexford Capital's MediciNova position peaked at $1.56M in Q3 2018.
49 funds tracked by Wall St. Rank held MediciNova as of Q3 2019.

Based on Wexford Capital's 13F filing for Q3 2019, filed 14 Nov 2019.